Medical Doctor Program year 2025 Reported 2019–2025 Source: CMS Open Payments, 2026 publication

Adam Lipson

Neurological Surgery Union, NJ Medical Doctor

NPI 1912012071 CMS profile 41277

1057 Commerce Ave, Union, NJ 07083

Open in the dashboard

General payments

$187,456

356 records reported · program years 2019–2025

Research payments

$3,000

Paid to them · 10 records reported · program years 2019–2025

Ownership & investment interest

$21,319

1 holding reported · through program year 2025

Through program year 2025, Adam Lipson of Union, NJ is reported in the CMS Open Payments database as having received $187,456 across 356 general payments and $3,000 in research payments paid to them. They also declared ownership or investment interests valued at $21,319 across 1 holding.

No combined total General, research and ownership are kept apart. Each is reported under its own rules, and ownership is not money that moved at all but the value of a stake held. A meal, a clinical trial grant and a shareholding do not add up to anything meaningful, so this site does not add them.

General payments for this record sit in the 94th percentile of Neurological Surgery profiles with reported payments. Percentile describes the distribution, not the conduct.

By program year

9 rows
Year Kind Relative to this record's peak year Amount Records
2025 General $34,250 66
2024 General $44,984 78
2024 Research $3,000 10
2023 General $27,496 51
2022 General $17,601 32
2021 General $16,098 35
2020 General $20,063 24
2019 General $26,965 70
2019 Ownership $21,319 1

Beside peers

Year by year, beside peers General payments · among profiles paid that year
  • Adam Lipson
  • Neurological Surgery median
  • Middle half of Neurological Surgery
  • National median

In program year 2025, general payments to Adam Lipson were reported at $34,250. Among 5,467 Neurological Surgery profiles paid that year, the median was $596 and the middle half received between $159 and $3,102.

Show as a table
Year Adam Lipson Neurological Surgery median Middle half National median
2019 $26,965 $582 $138–$3,006 $163
2020 $20,063 $294 $76–$2,174 $114
2021 $16,098 $387 $105–$2,432 $132
2022 $17,601 $542 $139–$2,989 $149
2023 $27,496 $534 $145–$2,697 $160
2024 $44,984 $574 $155–$3,046 $164
2025 $34,250 $596 $159–$3,102 $169

Breakdown

Who paid General payments · program years 2019–2025
  1. Intrinsic Therapeutics $68,238 91 payments
  2. Stryker Corporation $51,774 46 payments
  3. Royal Biologics $13,081 27 payments
  4. Centinel Spine, LLC $11,772 10 payments
  5. BIOTRONIK NRO, Inc. $10,965 10 payments
  6. Alphatec Spine, Inc $8,483 24 payments
  7. Medical Device Business Services, Inc. $6,485 4 payments
  8. VB Spine LLC $5,361 8 payments
  9. Becton, Dickinson and Company $5,075 2 payments
  10. Abbott Laboratories $1,747 46 payments
  11. Other $4,474 88 payments

Every payment, record by record

What the payments were for General payments · program years 2019–2025
  1. Consulting Fee $130,450 85 payments
  2. Compensation for serving as faculty or as a speaker for a medical education program $25,250 22 payments
  3. Travel and Lodging $15,269 37 payments
  4. Food and Beverage $12,831 200 payments
  5. Royalty or License $3,654 11 payments
  6. Education $2 1 payment
Products named General payments · program years 2019–2025
  1. BARRICAID ACD (ANNULAR CLOSURE DEVICE) Annular Closure Device $56,790 86 payments
  2. BARRICAID ACD (ANNULAR CLOSURE DEVICE) Annular Closure Device $56,790 86 payments
  3. ES2 $25,312 7 payments
  4. TRITANIUM $24,758 13 payments
  5. VLIFT $19,256 3 payments
  6. BARRICAID ACD (ANNULAR CLOSURE DEVICE) Orthopedic $11,415 4 payments
  7. Prospera $10,818 8 payments
  8. PRODISC L $10,490 6 payments
  9. Fibrinet $8,735 18 payments
  10. Other - Miscellaneous $8,230 19 payments
  11. Other $38,113 185 payments

A payment can name more than one product, so these amounts overlap and do not add up to the general-payment figure.

Research payments came from Research payments · program years 2019–2025
  1. Intrinsic Therapeutics $3,000 10 payments

Billing to Medicare

Part B · data year 2024 · 64 billing codes

Paid by Medicare

$100,368

Medicare's payments for the services billed

Medicare patients

144

Average age 70

Services billed

439

77 women, 67 men among their patients

Share of this provider's Medicare patients with each condition
Condition among their Medicare patients Relative to the most common Share of patients
High blood pressure 75%
Arthritis 75%
Diabetes 44%
Ischemic heart disease 33%
Depression 31%
Chronic kidney disease 22%
COPD 22%
Atrial fibrillation 20%

Medicare Part B only: services billed to Medicare. Rows covering fewer than 11 beneficiaries are not published. Only drugs given in the clinic are itemised here; the rest of what this provider billed is in the total above.

Records

366 reported

Every payment, record by record

Date, company, amount, what it was for and the product named — filter by year, kind and company, or download as CSV.

Other Neurological Surgery in New Jersey

Related records

What this means

U.S. law requires drug and medical device manufacturers to report payments and transfers of value they make to physicians and teaching hospitals. The Centers for Medicare & Medicaid Services publishes that record each year. This page shows what was reported about this person, and nothing else.

An ownership interest is different from the other two. It is not a payment: it is a stake — shares, options, a partnership holding — that a physician or an immediate family member held in a manufacturer during that year. The figure shown is what the stake was reported to be worth.

Research payments frequently pass through a clinician to the institution running a trial, and rarely represent personal income. They should be read differently from general payments.

Provenance

Source: CMS Open Payments · through program year 2025

Data current to program year 2025, from CMS's 2026 publication.

We reproduce what manufacturers reported. We do not verify, edit or correct the underlying records.

A payment record is not evidence of wrongdoing. Financial relationships between industry and medicine are legal, common and often necessary for research. Who Paid My Doc reports what was disclosed; it does not judge it.

Who Paid My Doc is independent and is not affiliated with, endorsed by or sponsored by CMS or any U.S. government agency. It is not a consumer reporting agency and this is not a consumer report; do not use it for decisions covered by the Fair Credit Reporting Act.

How to dispute or correct a record